Last reviewed · How we verify
NCT01329926
Molecular Analysis of Human Neural Stem Cells
trial testing Harvesting of neural stem cells in Parkinson's Disease. Withdrawn.
31 December 2022
Quick facts
| Lead sponsor | NeuroGeneration |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 30 June 2011 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Harvesting of neural stem cells
Conditions studied
- Parkinson's Disease — all drugs for Parkinson's Disease →
- Parkinsonism — all drugs for Parkinsonism →
Sponsor
NeuroGeneration — full company profile →
Who can join
Adults 35 to 85, any sex, with Parkinson's Disease or Parkinsonism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to develop and optimize methods to isolate, propagate and differentiate adult human neural stem cells from patients with degenerative neurological disorders like Parkinson's disease.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review.
Vishwakarma SK, Bardia A, Tiwari SK, Paspala SA, et al · · 2014 · cited 68× · PMID 25685495 · DOI 10.1016/j.jare.2013.04.005 -
An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.
Guo H, Zhao Z, Yang Q, Wang M, et al · · 2013 · cited 51× · PMID 23554499 · DOI 10.1523/jneurosci.4491-12.2013 -
Stem cell transplantation in neurological diseases: improving effectiveness in animal models.
Adami R, Scesa G, Bottai D. · · 2014 · cited 27× · PMID 25364724 · DOI 10.3389/fcell.2014.00017 -
Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells.
Pantcheva P, Reyes S, Hoover J, Kaelber S, et al · · 2015 · cited 20× · PMID 26394528 · DOI 10.1586/14737175.2015.1091727 -
Neural Cells for Neurodegenerative Diseases in Clinical Trials.
Fan Y, Goh ELK, Chan JKY. · · 2023 · cited 17× · PMID 37487111 · DOI 10.1093/stcltm/szad041 -
Current Status of Stem Cell-Derived Therapies for Parkinson's Disease: From Cell Assessment and Imaging Modalities to Clinical Trials.
Jang SE, Qiu L, Chan LL, Tan EK, et al · · 2020 · cited 16× · PMID 33177975 · DOI 10.3389/fnins.2020.558532
Verify or expand the search:
- PubMed search for NCT01329926
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson's Disease
Currently open trials in the same condition.
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07330258 — A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite · recruiting
- NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
- NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
- NCT06562569 — Non-invasive VNS for PD Gait · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01329926 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NeuroGeneration
- Last refreshed: 12 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01329926.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing